Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000621883> ?p ?o ?g. }
Showing items 1 to 94 of
94
with 100 items per page.
- W2000621883 endingPage "967" @default.
- W2000621883 startingPage "962" @default.
- W2000621883 abstract "Background Melasma is often recalcitrant to treatment. Triple combination (TC) cream is an effective and approved treatment for melasma. Objective We sought to determine the efficacy and safety of continuous therapy followed by a maintenance treatment regimen during a period of 24 weeks with a TC cream containing hydroquinone 4%, tretinoin 0.05%, and fluocinolone acetonide 0.01%. Methods Seventy patients with melasma were treated with a TC cream daily for 12 weeks, after which, if clear or almost clear, they applied the cream twice per week for 12 more weeks. For patients who were not clear or almost clear after 12 weeks, daily treatment was continued. Results In all, 25 patients completing the study per protocol were treated daily for 24 weeks (cohort A); 6 patients were treated daily for 12 weeks followed by 12 weeks of maintenance therapy (cohort B); and 21 patients were treated daily for 12 weeks, relapsed during the maintenance phase, and returned to daily dosing (cohort C). Pigmentation was significantly reduced at weeks 12 and 24 and global melasma severity improved at week 24 in cohorts A and C compared with baseline. Adverse events occurred in 53% of patients and were primarily mild in severity. Limitations This was an open-label trial. Conclusion About half of patients treated with a TC cream for melasma were able to begin maintenance therapy twice per week after 12 weeks; however, relapses occurred in most of these patients, requiring resumption of daily therapy. The cream is safe in the treatment of moderate to severe melasma for up to 24 weeks when used intermittently or continuously. Significant reductions in melasma severity scores were seen at weeks 12 and 24 when compared with baseline scores in all evaluable study groups Melasma is often recalcitrant to treatment. Triple combination (TC) cream is an effective and approved treatment for melasma. We sought to determine the efficacy and safety of continuous therapy followed by a maintenance treatment regimen during a period of 24 weeks with a TC cream containing hydroquinone 4%, tretinoin 0.05%, and fluocinolone acetonide 0.01%. Seventy patients with melasma were treated with a TC cream daily for 12 weeks, after which, if clear or almost clear, they applied the cream twice per week for 12 more weeks. For patients who were not clear or almost clear after 12 weeks, daily treatment was continued. In all, 25 patients completing the study per protocol were treated daily for 24 weeks (cohort A); 6 patients were treated daily for 12 weeks followed by 12 weeks of maintenance therapy (cohort B); and 21 patients were treated daily for 12 weeks, relapsed during the maintenance phase, and returned to daily dosing (cohort C). Pigmentation was significantly reduced at weeks 12 and 24 and global melasma severity improved at week 24 in cohorts A and C compared with baseline. Adverse events occurred in 53% of patients and were primarily mild in severity. This was an open-label trial. About half of patients treated with a TC cream for melasma were able to begin maintenance therapy twice per week after 12 weeks; however, relapses occurred in most of these patients, requiring resumption of daily therapy. The cream is safe in the treatment of moderate to severe melasma for up to 24 weeks when used intermittently or continuously. Significant reductions in melasma severity scores were seen at weeks 12 and 24 when compared with baseline scores in all evaluable study groups" @default.
- W2000621883 created "2016-06-24" @default.
- W2000621883 creator A5009752673 @default.
- W2000621883 creator A5013336660 @default.
- W2000621883 creator A5056537776 @default.
- W2000621883 creator A5069964766 @default.
- W2000621883 creator A5074284328 @default.
- W2000621883 creator A5076678927 @default.
- W2000621883 creator A5087257298 @default.
- W2000621883 date "2010-06-01" @default.
- W2000621883 modified "2023-10-14" @default.
- W2000621883 title "Continuous therapy followed by a maintenance therapy regimen with a triple combination cream for melasma" @default.
- W2000621883 cites W1987813817 @default.
- W2000621883 cites W2055984976 @default.
- W2000621883 cites W2060540686 @default.
- W2000621883 cites W2077847846 @default.
- W2000621883 cites W2080116170 @default.
- W2000621883 cites W2122423912 @default.
- W2000621883 cites W2136431078 @default.
- W2000621883 cites W2161999508 @default.
- W2000621883 cites W2162913078 @default.
- W2000621883 cites W4230145997 @default.
- W2000621883 doi "https://doi.org/10.1016/j.jaad.2009.06.067" @default.
- W2000621883 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20398959" @default.
- W2000621883 hasPublicationYear "2010" @default.
- W2000621883 type Work @default.
- W2000621883 sameAs 2000621883 @default.
- W2000621883 citedByCount "35" @default.
- W2000621883 countsByYear W20006218832012 @default.
- W2000621883 countsByYear W20006218832013 @default.
- W2000621883 countsByYear W20006218832014 @default.
- W2000621883 countsByYear W20006218832015 @default.
- W2000621883 countsByYear W20006218832016 @default.
- W2000621883 countsByYear W20006218832017 @default.
- W2000621883 countsByYear W20006218832018 @default.
- W2000621883 countsByYear W20006218832019 @default.
- W2000621883 countsByYear W20006218832020 @default.
- W2000621883 countsByYear W20006218832021 @default.
- W2000621883 countsByYear W20006218832022 @default.
- W2000621883 countsByYear W20006218832023 @default.
- W2000621883 crossrefType "journal-article" @default.
- W2000621883 hasAuthorship W2000621883A5009752673 @default.
- W2000621883 hasAuthorship W2000621883A5013336660 @default.
- W2000621883 hasAuthorship W2000621883A5056537776 @default.
- W2000621883 hasAuthorship W2000621883A5069964766 @default.
- W2000621883 hasAuthorship W2000621883A5074284328 @default.
- W2000621883 hasAuthorship W2000621883A5076678927 @default.
- W2000621883 hasAuthorship W2000621883A5087257298 @default.
- W2000621883 hasConcept C126322002 @default.
- W2000621883 hasConcept C141071460 @default.
- W2000621883 hasConcept C16005928 @default.
- W2000621883 hasConcept C197934379 @default.
- W2000621883 hasConcept C2776677263 @default.
- W2000621883 hasConcept C2776694085 @default.
- W2000621883 hasConcept C2777288759 @default.
- W2000621883 hasConcept C2777463590 @default.
- W2000621883 hasConcept C2778283404 @default.
- W2000621883 hasConcept C2781413609 @default.
- W2000621883 hasConcept C71924100 @default.
- W2000621883 hasConcept C72563966 @default.
- W2000621883 hasConceptScore W2000621883C126322002 @default.
- W2000621883 hasConceptScore W2000621883C141071460 @default.
- W2000621883 hasConceptScore W2000621883C16005928 @default.
- W2000621883 hasConceptScore W2000621883C197934379 @default.
- W2000621883 hasConceptScore W2000621883C2776677263 @default.
- W2000621883 hasConceptScore W2000621883C2776694085 @default.
- W2000621883 hasConceptScore W2000621883C2777288759 @default.
- W2000621883 hasConceptScore W2000621883C2777463590 @default.
- W2000621883 hasConceptScore W2000621883C2778283404 @default.
- W2000621883 hasConceptScore W2000621883C2781413609 @default.
- W2000621883 hasConceptScore W2000621883C71924100 @default.
- W2000621883 hasConceptScore W2000621883C72563966 @default.
- W2000621883 hasIssue "6" @default.
- W2000621883 hasLocation W20006218831 @default.
- W2000621883 hasLocation W20006218832 @default.
- W2000621883 hasOpenAccess W2000621883 @default.
- W2000621883 hasPrimaryLocation W20006218831 @default.
- W2000621883 hasRelatedWork W1481792414 @default.
- W2000621883 hasRelatedWork W1984394301 @default.
- W2000621883 hasRelatedWork W2287093613 @default.
- W2000621883 hasRelatedWork W2810178649 @default.
- W2000621883 hasRelatedWork W3165570020 @default.
- W2000621883 hasRelatedWork W4205238521 @default.
- W2000621883 hasRelatedWork W4226334817 @default.
- W2000621883 hasRelatedWork W4287317386 @default.
- W2000621883 hasRelatedWork W4289545023 @default.
- W2000621883 hasRelatedWork W4221143783 @default.
- W2000621883 hasVolume "62" @default.
- W2000621883 isParatext "false" @default.
- W2000621883 isRetracted "false" @default.
- W2000621883 magId "2000621883" @default.
- W2000621883 workType "article" @default.